title: The role of oxidative stress and NF-kappaB activation in late diabetic complications.
abstract: A common endpoint of hyperglycemia dependent cellular changes is the generation of reactive oxygen intermediates (ROIs) and the presence of elevated oxidative stress. Therefore, oxidative stress is supposed to play an important role in the development of late diabetic complications. Formation of advanced glycation end products (AGE's) due to elevated nonenzymatic glycation of proteins, lipids and nucleic acids is accompanied by oxidative, radical-generating reactions and thus represents a major source for oxygen free radicals under hyperglycemic conditions. Once formed, AGE's can influence cellular function by binding to several binding sites including the receptor for AGE's, RAGE. Binding of AGE's (and other ligands) to RAGE results in generation of intracellular oxidative stress and subsequent activation of the redox-sensitive transcription factor NF-kappaB in vitro and in vivo. Consistently, activation of NF-kappaB in diabetic patients correlates with the quality of glycemic control and can be reduced by treatment with the antioxidant alpha-lipoic acid. The development of techniques allowing for a tissue culture independent measurement of NF-kappaB activation in patients with diabetes mellitus gives insights into the molecular mechanisms linking diabetes mellitus and hyperglycemia with formation of advanced glycated endproducts and generation of oxidative stress finally resulting in oxidative stress mediated cellular activation.
authors.affiliation: Medizinische Klinik I der Universitat Heidelberg, Germany.
authors.forename: A K
authors.initials: AK
authors.lastname: Mohamed
authors.forename: A
authors.initials: A
authors.lastname: Bierhaus
authors.forename: S
authors.initials: S
authors.lastname: Schiekofer
authors.forename: H
authors.initials: H
authors.lastname: Tritschler
authors.forename: R
authors.initials: R
authors.lastname: Ziegler
authors.forename: P P
authors.initials: PP
authors.lastname: Nawroth
mesh_terms: D000818:Animals; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology*; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D016328:NF-kappa B / Q000378:metabolism*; D018384:Oxidative Stress / Q000502:physiology*
chemical_list: D017127:Glycation End Products, Advanced; D016328:NF-kappa B